drug discovery tool

A unique collection of 3170 approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2073 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1920 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

Novel Bioactive Compound Library is a collection of 8582 bioactive compounds

A unique collection of 1490 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of 523 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening;

A unique collection of 1600 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of 4986 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 1639 compounds from food as medicine for high throughput and high content screening;

A collection of 1321 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study;

A unique collection of 3128 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism;

A unique collection of 373 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 5745 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2440 compounds with anti-breast cancer therapeutic activity or targeting breast cancer's major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study;

A unique collection of 941 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;

A unique collection of 246 fragment-like small molecules for FBDD;

Mini Cysteine Covalent Inhibitors Library collection features 768 compounds with cysteine covalent binding potential

A unique collection of 18811 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;

A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening;

A unique collection of 2240 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.

A unique collection of 950 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study;

1119 drug fragments,a must-have tool for FBDD;